Single-cell RNA sequencing (scRNA-seq) technology is revolutionizing our understanding of cellular heterogeneity within complex tissues and RNA transcripts. However, navigating the nuances of scRNA-seq data is crucial for accurate downstream analyses.

In this webinar, you’ll discover how SPR can be multiplexed and automated to enable high-throughput, data-rich drug candidate screening against multiple target proteins.

In this webinar, our expert speaker will present a new approach – using nanopore adaptive sampling for comprehensive methylation profiling.

Dr. Yuan Liu from Indiana University will be joining Technology Networks to provide a comprehensive overview of this promising field, paving the way for potential therapeutics.

Join us for an exclusive opportunity to speak directly with Dr. David Baltimore, a distinguished figure in this field and a Nobel Laureate, as he navigates the complexities of CRISPR genome editing technology.

Cell therapies often involve introduction of genetically transformed cells into a patient. Recently there has been renewed interest in non-viral gene modification for this application as an alternative to lentiviral vectors.